Report on the Public Consultation on eHealth Action Plan 2012-2020

Report on the Public Consultation on eHealth Action Plan 2012-2020
In December 2009, Member States adopted the Council Conclusions on Safe and efficient healthcare through eHealth1, in which the Council specifically called on the Commission to "update the eHealth Action Plan". A public consultation is a mandatory exercise to give stakeholders the opportunity to give their opinion on any important European initiative. The public consultation was launched on 31 March 2011 and closed on 30 May 2011. The consultation sought to validate four proposed objectives and to explore possible actions to be undertaken in next years. The four objectives proposed were:

  • Objective 1: Increase awareness of the benefits and opportunities of eHealth, and empower citizens, patients and healthcare professionals.
  • Objective 2: Address issues currently impeding eHealth interoperability
  • Objective 3: Improve legal certainty for eHealth
  • Objective 4: Support research and innovation in eHealth and development of a competitive European market.

239 participants contributed to the consultation representing different stakeholders including non-governmental organisations, academia, enterprises, health and social care providers and public authorities from many Member States.

Download Report on the Public Consultation on eHealth Action Plan 2012-2020 (.pdf, 202 KB).

Download from eHealthNews.eu Portal's mirror: Report on the Public Consultation on eHealth Action Plan 2012-2020 (.pdf, 202 KB).

Most Popular Now

Researchers Capture First Images of Oxyg…

Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful. Hypoxia, or starvation of oxygen, in solid tumors is also thought to be...

VTT Makes New Investments in Digital Hea…

VTT is launching new research activities in the area of digital health as part of the growing wellbeing and health technology ecosystem in Kuopio. The new initiative aims to create...

A New Method of Artificial Intelligence …

Despite the immense progress in the field of AI in recent years, we are still very far from human intelligence. Indeed, if current AI techniques allow to train computer agents...

FDA Informs Health Care Providers, Facil…

Today, the U.S. Food and Drug Administration is issuing a safety communication informing health care providers, facilities and patients about cybersecurity vulnerabilities identified for certain GE Healthcare Clinical Information Central...

eHealthWeek 2020 Croatia - Trusted Infor…

15 - 17 April 2020, Rovinj, Croatia. In its capacity of hosting the upcoming Presidency of the Council of the European Union, the Croatian Ministry of Health is in preparations to...

Siemens Healthineers Presents Solutions …

CT scanners with intelligent user guidance, AI-based software assistants for MRI and a lab system that revolutionizes workflows: Siemens Healthineers is showcasing its products and solutions according to the motto...

NHS IT Chiefs Set the Stage for a Year o…

3 - 4 March 2019, London, United Kingdom. NHS technology leaders are to kick off the second-ever Digital Health Rewired Conference and Exhibition on 3 - 4 March at the Olympia...

PatchAi Startup has Arrived in the Marke…

PatchAi - a startup that offers, thanks to Artificial Intelligence and Machine Learning, an empathic virtual assistant to patients participating in clinical trials - announced that it has closed two...

Digital Health App Medicus AI Earns CE C…

Medicus AI, the Vienna-based health tech company, has received a ​Class I Medical Device CE Mark for its mobile application. The CE certification mark confirms that Medicus AI conforms to...

FDA Authorizes Marketing of First Cardia…

Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professionals in the acquisition of cardiac ultrasound, or echocardiography, images. The software, called Caption Guidance, is...

Human Body-on-Chip Platform Enables In V…

Drug development is an extremely arduous and costly process, and failure rates in clinical trials that test new drugs for their safety and efficacy in humans remain very high. According...

AI in Drug Discovery Conference 2020

16 - 17 March 2020, London, UK. SMi group presents the launch of the inaugural AI in Drug Discovery conference taking place in London. AI-empowered machine learning technologies hold the potential...